By 2023, FDA had cleared 692 AI or ML enabled medical devices, and radiology accounted for 74% of them, showing how quickly imaging moved from research to real-world care. At the same time, adoption is uneven across the system with 62% of hospitals integrating AI medical devices by end of 2023 and just 45% of US radiologists using AI tools daily in 2024. The rest of the dataset gets even more specific, from 87.2% sensitivity in an FDA cleared diabetic retinopathy screener to multi billion dollar investment and fast market growth through 2030.
Key Takeaways
- 87% of medical device companies reported increased AI adoption in 2023 surveys.
- 62% of hospitals integrated AI medical devices by end of 2023.
- 45% of U.S. radiologists use AI tools daily in 2024 surveys.
- Clinical accuracy of IDx-DR AI diabetic retinopathy screener is 87.2% sensitivity, FDA cleared.
- Viz.ai stroke detection AI achieves 92% sensitivity and 95% specificity in trials.
- Aidoc's AI for pulmonary embolism detection has 94% sensitivity per peer-reviewed studies.
- Over $15.3 billion invested in AI healthcare startups globally in 2023, with 25% to med devices.
- Medtronic invested $1.2 billion in AI R&D for devices in FY2023.
- Siemens Healthineers AI portfolio funding $500 million in 2023.
- The global AI in medical devices market was valued at USD 6.1 billion in 2022 and is projected to reach USD 18.7 billion by 2030, growing at a CAGR of 14.1%.
- North America dominated the AI medical devices market with a 40.2% revenue share in 2022, driven by advanced healthcare infrastructure.
- The software segment accounted for 58.3% of the AI in medical devices market revenue in 2022 due to rising demand for diagnostic tools.
- FDA cleared 692 AI/ML-enabled medical devices as of September 2023.
- 74% of FDA-cleared AI devices are for radiology applications in 2023.
- First AI software as medical device approved in EU under MDR in 2021, with 200+ by 2024.
Medical device AI adoption is accelerating fast, with expanding hospital use, clear regulatory approvals, and major investment driving growth.
Related reading
01 · Category
Adoption And Implementation24 stats
01
87% of medical device companies reported increased AI adoption in 2023 surveys.
02
62% of hospitals integrated AI medical devices by end of 2023.
03
45% of U.S. radiologists use AI tools daily in 2024 surveys.
04
71% of medical device firms plan AI expansion in next 2 years per 2023 PwC report.
05
Adoption rate of AI in surgical devices reached 38% in top 500 hospitals in 2023.
06
54% of European clinics adopted AI diagnostics devices by 2023.
07
In Asia, 29% growth in AI medical device installations from 2022-2023.
08
67% of cardiologists report using AI-enabled ECG devices routinely.
09
52% of orthopedic surgeons integrated AI planning tools in 2023.
10
Global survey shows 41% of medtech companies have AI in >50% of products by 2024.
11
73% of U.S. hospitals piloted AI wearables in 2023.
12
36% increase in AI device procurement by NHS trusts in UK 2023.
13
48% of Japanese hospitals use AI imaging systems as of 2024.
14
59% of private practices in India adopted AI diagnostics in 2023.
15
64% of med device manufacturers report full AI integration in R&D by 2024.
16
39% of Canadian healthcare facilities use AI prosthetics fitting tools.
17
55% adoption rate for AI endoscopy in gastroenterology clinics worldwide.
18
42% of Australian hospitals implemented AI ventilators post-2022.
19
51% of Brazilian med centers use AI infusion systems in 2024.
20
66% of German firms lead in AI neuromodulation device deployment.
21
47% growth in AI dialysis machine use in EU hospitals 2023.
22
63% of top 100 med device cos have AI governance frameworks in 2024.
23
35% of small clinics worldwide adopted AI hearing aids by 2023.
24
58% of dental practices in US use AI imaging analysis tools.
Interpretation
Adoption And Implementation Interpretation
By the end of 2023, adoption was moving quickly with 62% of hospitals already integrating AI medical devices and 87% of companies reporting increased AI adoption, while plans to expand AI remained strong as 71% of firms expected to grow their use in the next two years.
02 · Category
Clinical Performance25 stats
01
Clinical accuracy of IDx-DR AI diabetic retinopathy screener is 87.2% sensitivity, FDA cleared.
02
Viz.ai stroke detection AI achieves 92% sensitivity and 95% specificity in trials.
03
Aidoc's AI for pulmonary embolism detection has 94% sensitivity per peer-reviewed studies.
04
PathAI pathology AI reduces error rates by 25% in cancer diagnostics.
05
Butterfly iQ+ AI ultrasound autobladder volume accuracy 95.2% vs manual.
06
Caption Health AI echo acquisition success rate 98% in novice users.
07
Eko AI ECG for LVEF prediction AUC 0.975 in validation.
08
HeartFlow FFRct AI analysis 90% accuracy vs invasive cath.
09
QuantX MRI breast cancer AI sensitivity 94%, specificity 81%.
10
RapidAI thrombectomy AI reduces door-to-puncture time by 30 minutes average.
11
Siemens AI-Rad Companion chest CT nodule detection FROC score 0.912.
12
GE Healthcare Critical Care Suite AI sepsis prediction AUC 0.89.
13
Medtronic GI Genius colonoscopy polyp detection 99.7% sensitivity.
14
Stryker Q Guidance AI spine surgery navigation accuracy 1.2mm.
15
Intuitive Surgical da Vinci AI tissue recognition error reduction 40%.
16
Abbott NeuroSphere AI DBS therapy optimization reduces symptoms by 52%.
17
Insulet Omnipod AI insulin dosing accuracy 93% within target range.
18
Dexcom G7 AI CGM predictive alerts reduce hypo events by 87%.
19
AliveCor Kardia AI AFib detection 98% sensitivity, 97% specificity.
20
iCad ProFound AI mammography cancer detection 8.8% uplift.
21
Vuno Med-LungCT AI pneumonia severity score correlation 0.92 with CTSS.
22
Aidoc fracture detection AI 96% sensitivity on X-rays.
23
EchoNous Kosmos AI cardiac ultrasound EF estimation RMSE 5.2%.
24
Paige Prostate AI biopsy concordance 92% with pathologists.
25
Tempus AI oncology matching accuracy 85% to clinical trials.
Interpretation
Clinical Performance Interpretation
Across clinical performance metrics, multiple AI medical devices are showing strong and measurable results, such as sensitivity in the low to mid 90s like 92% for stroke detection and 94% for pulmonary embolism, alongside high workflow accuracy like 98% echo acquisition success and 95.2% ultrasound volume accuracy.
03 · Category
Investment And Funding10 stats
01
Over $15.3 billion invested in AI healthcare startups globally in 2023, with 25% to med devices.
02
Medtronic invested $1.2 billion in AI R&D for devices in FY2023.
03
Siemens Healthineers AI portfolio funding $500 million in 2023.
04
Johnson & Johnson $800 million AI medtech venture fund launched 2023.
05
GE Healthcare AI acquisitions totaled $300 million in 2023.
06
Philips $450 million investment in AI imaging devices 2022-2023.
07
Boston Scientific $250 million AI cardiology device funding.
08
Abbott Laboratories $600 million AI diagnostics expansion.
09
Intuitive Surgical $1.1 billion capex on AI robotics 2023.
10
Stryker $400 million AI surgical tech investments FY2023.
Interpretation
Investment And Funding Interpretation
In the investment and funding picture, 2023 saw more than $15.3 billion flow into AI healthcare startups globally with roughly 25% aimed at medical devices, while major medtech players backed that momentum with major commitments like Medtronic’s $1.2 billion AI device R and D and Johnson and Johnson’s $800 million medtech venture fund.
More related reading
04 · Category
Market Size And Growth29 stats
01
The global AI in medical devices market was valued at USD 6.1 billion in 2022 and is projected to reach USD 18.7 billion by 2030, growing at a CAGR of 14.1%.
02
North America dominated the AI medical devices market with a 40.2% revenue share in 2022, driven by advanced healthcare infrastructure.
03
The software segment accounted for 58.3% of the AI in medical devices market revenue in 2022 due to rising demand for diagnostic tools.
04
Asia Pacific AI medical devices market is expected to grow at the fastest CAGR of 15.8% from 2023 to 2030, fueled by increasing healthcare investments.
05
The diagnostics segment led the AI medical devices market with a 39.4% share in 2022, owing to high adoption in radiology.
06
AI in medical imaging devices market size was USD 1.8 billion in 2023 and is anticipated to expand at a CAGR of 32.4% from 2024 to 2032.
07
U.S. AI medical devices market held over 35% share in 2023, supported by FDA approvals and R&D investments.
08
Hardware segment in AI medical devices is projected to grow at 13.8% CAGR through 2030 due to integration with robotics.
09
Europe AI medical devices market revenue reached USD 2.3 billion in 2022, with Germany leading at 28% share.
10
Global AI-powered surgical robots market valued at USD 7.2 billion in 2023, expected to hit USD 20.5 billion by 2030 at 16.1% CAGR.
11
The wearable AI medical devices segment is forecasted to grow from USD 12.4 billion in 2023 to USD 45.6 billion by 2032 at 15.6% CAGR.
12
China’s AI medical devices market expanded by 22.4% YoY in 2023, reaching USD 1.9 billion.
13
AI diagnostics devices market size stood at USD 3.5 billion in 2022, projected to grow at 28.7% CAGR to 2030.
14
Latin America AI medical devices market is expected to register a CAGR of 12.5% from 2024 to 2032.
15
The neurological disorders segment in AI medical devices held 25.6% market share in 2023.
16
AI in cardiology devices market valued at USD 2.1 billion in 2023, with 18.3% CAGR forecast to 2030.
17
Middle East & Africa AI medical devices market grew 14.2% in 2023 to USD 0.8 billion.
18
Orthopedics AI devices segment projected at USD 1.2 billion by 2028, CAGR 15.4%.
19
AI-enabled pacemakers market size was USD 4.5 billion in 2022, growing at 11.2% CAGR.
20
Respiratory AI devices market expected to reach USD 3.8 billion by 2030 at 16.7% CAGR from 2023 base of USD 1.4 billion.
21
AI in ophthalmology devices market valued at USD 0.9 billion in 2023, CAGR 29.1% to 2032.
22
Global AI hearing aids market size hit USD 2.3 billion in 2023, projected 14.8% CAGR.
23
Dental AI devices market grew to USD 1.1 billion in 2023, 20.5% CAGR expected.
24
AI prosthetics market valued at USD 0.7 billion in 2022, 17.9% CAGR to 2030.
25
Endoscopy AI market size was USD 1.5 billion in 2023, forecasted 22.3% CAGR.
26
AI infusion pumps market reached USD 0.6 billion in 2023, 13.4% CAGR projection.
27
Neuromodulation devices with AI valued at USD 5.2 billion in 2022, 12.8% CAGR.
28
AI ventilators market size USD 2.8 billion in 2023 post-pandemic boost, 15.1% CAGR.
29
Dialysis AI devices market at USD 3.1 billion in 2023, 14.6% CAGR to 2032.
Interpretation
Market Size And Growth Interpretation
The AI in medical devices market is set to triple from USD 6.1 billion in 2022 to USD 18.7 billion by 2030, with the fastest momentum coming from Asia Pacific at a 15.8% CAGR from 2023 to 2030, making growth dynamics a defining feature of the market size and growth outlook.
05 · Category
Regulatory Approvals24 stats
01
FDA cleared 692 AI/ML-enabled medical devices as of September 2023.
02
74% of FDA-cleared AI devices are for radiology applications in 2023.
03
First AI software as medical device approved in EU under MDR in 2021, with 200+ by 2024.
04
China's NMPA approved 52 AI medical devices in 2023 alone.
05
92% of cleared AI devices by FDA are SaMD (Software as Medical Device).
06
Japan PMDA granted approval to 28 AI diagnostics devices in 2023.
07
EU notified bodies reviewed 156 AI device submissions in 2023.
08
Australia's TGA approved 41 AI/ML medical devices by mid-2024.
09
67% of FDA AI clearances in 2023 were Class II devices.
10
Brazil ANVISA certified 19 AI imaging devices in 2023.
11
South Korea MFDS approved 35 AI medical devices in 2023.
12
Canada Health Canada authorized 24 AI SaMD in 2023-2024.
13
85% of EU AI devices under MDR are for ophthalmology and radiology.
14
India's CDSCO cleared 12 AI diagnostics tools by 2024.
15
Singapore HSA approved 15 AI medical devices in 2023.
16
56% increase in FDA AI submissions from 2022 to 2023.
17
UK MHRA approved 22 AI devices under new AI Air framework in 2024.
18
78% of cleared AI devices have cybersecurity requirements per FDA 2023.
19
103 AI devices received breakthrough designation from FDA by 2023.
20
40% of global AI approvals in 2023 were for cardiovascular applications.
21
FDA issued 14 AI/ML action plans updates since 2021.
22
AI device recall rate is 2.1% vs 1.8% for traditional devices per FDA 2023 data.
23
91% of AI approvals require premarket notification (510(k)).
24
29 AI devices approved for neurology by global regulators in 2023.
Interpretation
Regulatory Approvals Interpretation
Regulatory momentum for AI medical devices is accelerating worldwide, with the FDA clearing 692 AI/ML-enabled devices by September 2023 and 92% of those being SaMD, while the EU reached over 200 MDR AI software approvals by 2024 and China and Japan added 52 and 28 AI medical approvals in 2023 respectively.
report visual · Key figures
AI adoption is accelerating across medtech and clinical use
Surveys and implementations show rapid year-over-year uptake—from company adoption plans to daily use by clinicians.
87%
87% of medical device companies reported increased AI adoption in 2023 surveys.
62%
62% of hospitals integrated AI medical devices by end of 2023.
45%
45% of U.S. radiologists use AI tools daily in 2024 surveys.
71%
71% of medical device firms plan AI expansion in next 2 years per 2023 PwC report.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Catherine Wu. (2026, February 13). AI In The Medical Device Industry Statistics. Gitnux. https://gitnux.org/ai-in-the-medical-device-industry-statistics
MLA
Catherine Wu. "AI In The Medical Device Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ai-in-the-medical-device-industry-statistics.
Chicago
Catherine Wu. 2026. "AI In The Medical Device Industry Statistics." Gitnux. https://gitnux.org/ai-in-the-medical-device-industry-statistics.
Sources & references
82 datasets cited across this report · attribution is report-level